NeuroTherapia Gains $12.3M in Series B Funding to Advance Breakthrough Alzheimer’s Treatment
NeuroTherapia, Inc., a clinical-stage biotech company and Cleveland Clinic Innovations portfolio entity, has successfully completed the first close of its Series B financing with $12.3M raised. The financing round, led by Cleveland Clinic, sees continued support from Brain Trust Accelerator Fund II, Dolby Family Ventures, and the Alzheimer’s Drug Discovery Foundation (ADDF), with new investment…